Jessica Kendall - University of Leeds

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

INVEST: A Phase Ib Window of Opportunity Study of Atezolizumab Administered Either Intravesically or Direct Tumour Injection in Patients with Bladder Cancer Prior to Radical Cystectomy

Syed A. Hussain,Jamie B. Oughton, Ruby Smith Whelan,Angela Green,Rachel Hubbard,Steven Kennish, Ethan Senior,Jessica Kendall, Dominic Mccready,Fiona J. Collinson,Jon Griffin, James W. F. Catto

Journal of Clinical Oncology（2024）

引用0浏览0引用

Olaparib, AZD1390, Ceralasertib, Saruparib and Consolidation Durvalumab (CONCORDE) Phase Ib Platform Study of Novel DNA Damage Response Inhibitor (ddri) Agents in Combination with Radiotherapy in Non-Small Cell Lung Cancer (NSCLC)

Alastair Greystoke,Jamie B. Oughton,Sarah R. Brown,Karl Butterworth,Victoria Coyle,Kevin Franks, Adam Hassani,Stephen Harrow,Matthew Hatton,Crispin T. Hiley,Jessica Kendall,Rachel Phillip, Matthew Norris, Oluwaseun Ojo,Paul Shaw, Fiona Walker,Huiqi Yang,Anthony J. Chalmers,Corinne Faivre-Finn

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

1232: Modern Era Radical Radiotherapy Toxicity: a Preliminary CONCORDE Analysis of the Calibration Arm

Ashley Horne,Sarah Brown,Alexandra Gilbert,Vicky Coyle, Kevin Nicholas Franks, Adam Hassani, Stephen James Harrow,Matthew Hatton,Crispin Hiley,Jessica Kendall,Rachel Phillip, Matthew Norris,Jamie B. Oughton,Paul Shaw, Fiona Walker,Huiqi Yang,Anthony J. Chalmers, Alastair Greystoke,Corinne Faivre-Finn

Radiotherapy and Oncology (2024)

引用0浏览0引用

P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS

H Auner,S Brown,K Walker,J Kendall,B Dawkins,D Meads,G Morgan,M Kaiser,M Cook,S Roberts,C Parrish,G Cook

HemaSphere（2022）

引用6浏览0引用

A Phase IB and Randomised Phase IIA Trial of CApecitabine Plus Radium-223 (xofigo™) in Breast Cancer Patients with BONe Metastases: CARBON Trial Results

Matthew Winter,Rob Coleman,Jessica Kendall,Carlo Palmieri,Chris Twelves,Sacha Howell,Iain MacPherson,Caroline Wilson,Kash Purohit,Jacqui Gath, Christine Taylor,Richard Eastell,Geraldine Murden,Sarah R. Brown,Emma Rathbone,Janet Brown

Journal of bone oncology（2022）

引用4浏览0WOS引用

Abstract CT569: Combination of Reovirus (pelareorep) and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Alongside Standard Chemoradiotherapy and Adjuvant Chemotherapy (temozolomide) for Patients with Glioblastoma Multiforme (GBM): Long Term Follow Up Results of the ReoGlio Phase Ib Trial

Susan C. Short,Jessica Kendall,Anthony Chalmers,Catherine McBain,Alan Melcher,Adel Samson,Rachel Phillip,Sarah Brown

Cancer researchno. 12_Supplement (2022): CT569-CT569

引用0浏览0引用

MUKtwelve Protocol: a Phase II Randomised, Controlled, Open, Parallel Group, Multicentre Trial of Selinexor, Cyclophosphamide and Prednisolone (SCP) Versus Cyclophosphamide and Prednisolone (CP) in Patients with Relapsed or Refractory Multiple Myeloma

Jessica Kendall,Andrew Hall,Sadie Roberts,Sarah Brown,Kevin Boyd,Holger W. Auner,Mamta Garg,Martin Kaiser

BMJ open（2022）

引用0浏览0WOS引用

Abstract PS14-02: A Randomised Phase IB/IIA Study of CApecitabine Plus Radium-223 in Breast Cancer Patients with BONe Metastases (CARBON) - Safety and Preliminary Efficacy Findings

Matthew Winter,Jessica Kendall,Sarah Brown,Emma Rathbone,Caroline Wilson,Sacha Howell,Chris Twelves,Carlo Palmieri,Anjana Anand,Iain MacPherson,Rob Coleman,Janet Brown

Cancer Research（2021）

引用0浏览0引用

A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings

Matthew Winter,Jessica Kendall,Sarah Brown,Emma Rathbone,Caroline Wilson,Sacha Howell,Chris Twelves,Carlo Palmieri,Anjana Anand,Iain MacPherson,Rob Coleman,Janet Brown

CANCER RESEARCH（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn